Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Pharma sages april fda approvals

  • Login to see the comments

  • Be the first to like this

Pharma sages april fda approvals

  1. 1. PharmaSages_April FDA Approvals• Bausch and Lomb: PROLENSA is a nonsteroidal anti-inflammatory drug (NSAID) for thetreatment of postoperative inflammation and reduction of ocular pain in patients who haveundergone cataract surgery.• Taro: Topicort® (desoximetasone) Topical Spray, 0.25% is a corticosteroid indicated for thetreatment of plaque psoriasis.• Luminex: xTAG, a nucleic acid IVD test, to detect 11 different viral, bacterial and parasiticcauses of infectious gastroenteritis at the same time in a single fecal sample within fivehours.• Warner Chilcott: Minastrin 24 Fe is an estrogen/progestin combination oral contraceptive(COC) indicated for use by women to prevent pregnancy.• Duchesnay: Diclegis (a mixture of doxylamine succinate and pyroxidine hydrochloride) totreat morning sickness.• Dako: EP1 (FLEX Monoclonal Rabbit Anti-Human Estrogen Receptor alpha, Clone EP1) togauge the presence of nuclear estrogen receptor without cytoplasmic staining in breastcancer patients.• Actavis: Docetaxel Injection Concentrate for breast, non-small cell lung, prostate, gastricadenocarcinoma, head and neck cancer treatment.• Bioalliance Pharma SA: SITAVIG (acyclovir) for the treatment of recurrent herpes labialis(cold sores) in immunocompetent adults.• Alcon Res Ltd: SIMBRINZA™ (brinzolamide/brimonidine tartrate ophthalmic suspension)1%/0.2% is a combination of a carbonic anhydrase inhibitor and an alpha 2 adrenergicreceptor agonist indicated for the reduction of elevated intraocular pressure in patientswith open-angle glaucoma or ocular hypertension.
  2. 2. PharmaSages _ When to contact us?If you want….• Second opinion on your research• To reduce your R&D budget• To figure out growth strategy• To acquire specific talent or expertise• Help with clinical documents for FDA filings• To maximize ROI
  3. 3. Contact usAjay Shrivastava, CEOPharmaSages58 Magnolia LanePrinceton, NJ 08540Phone: (609)423-7602E-mail:asbiopro@pharmasages.comWeb: www.pharmasages.com

×